Support
Request a Demo
Menu
Life Sciences & Pharma
Real-World Evidence
Precision360
Precision Explorer
Translational360
Scientific Services
Patient360
Clinical Trials
ACT
TriaLinQ (CancerLinQ)
Precision360
Commercial
Cadence Suite
Data Foundry
Precision360
Precision GTM
CancerLinQ
TeraRecon
Advanced Visualization
TeraRecon AV
TeraRecon Intuition
Imaging Workflows
TeraRecon DETECT
TeraRecon AI Framework
Why We're Different
Get Resources
Newsroom
Events
Resource Hub
Publications
Product Manuals
About Us
Leadership
Investors
Careers
×
Life Sciences & Pharma
>
CancerLinQ
TeraRecon
>
Why We're Different
Get Resources
>
About Us
>
‹
Back
Life Sciences & Pharma
Real-World Evidence
›
Clinical Trials
›
Commercial
›
‹
Back
Real-World Evidence
Precision360
Precision Explorer
Translational360
Scientific Services
Patient360
‹
Back
Clinical Trials
ACT
TriaLinQ (CancerLinQ)
Precision360
‹
Back
Commercial
Cadence Suite
Data Foundry
Precision360
Precision GTM
‹
Back
TeraRecon
Advanced Visualization
›
Imaging Workflows
›
‹
Back
Advanced Visualization
TeraRecon AV
TeraRecon Intuition
‹
Back
Imaging Workflows
TeraRecon DETECT
TeraRecon AI Framework
‹
Back
Get Resources
Newsroom
Events
Resource Hub
Publications
Product Manuals
‹
Back
About Us
Leadership
Investors
Careers
Support
›
Request a Demo
›
Search
3395 / 15 Investigating clinical features and molecular mechanisms of long-term response and acquired resistance to immunotherapy in non-small cell lung cancer by applying real-world-data
2025
Wu S, Zhao W, Zhang B, Choi C, Akhand SS, Zhang Q, Chen J, Ansell P, Chen R, Zhao X, Samayoa J
Read more